COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer (PAZOFOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02055690
Recruitment Status : Terminated (Safety)
First Posted : February 5, 2014
Last Update Posted : October 29, 2018
Mateon Therapeutics
East and North Hertfordshire NHS Trust
Information provided by (Responsible Party):
Heather Driscoll, The Christie NHS Foundation Trust

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 24, 2017
Actual Study Completion Date : November 24, 2017